- Filed
- Feb 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Feb 9, 2026 | 5.45M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2025 | 8.94M sh |
| Shares Diluted restated | Q1 2026 · Dec 31, 2024 | 42.03K sh |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.45M |
| Cash And Equivalents | Q1 2026 · Sep 30, 2025 | $1.67M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $18.84M |
| Stockholders Equity | Q1 2026 · Sep 30, 2025 | $2.3M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.21M |
| Current Liabilities | Q1 2026 · Sep 30, 2025 | $2.46M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.24M |
| Total Liabilities | Q1 2026 · Sep 30, 2025 | $2.5M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.11M |
| Current Assets | Q1 2026 · Sep 30, 2025 | $2.24M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $20.7M |
| Total Assets | Q1 2026 · Sep 30, 2025 | $4.44M |
| Eps Diluted | Q1 2026 · Dec 31, 2025 | −$2.08 |
| Eps Diluted restated | Q1 2026 · Dec 31, 2024 | −$417.53 |
| Eps Basic | Q1 2026 · Dec 31, 2025 | −$2.08 |
| Eps Basic restated | Q1 2026 · Dec 31, 2024 | −$417.53 |
| Sga Expense | Q1 2026 · Dec 31, 2025 | $13.35M |
| Sga Expense restated | Q1 2026 · Dec 31, 2024 | $2.57M |
| Rd Expense | Q1 2026 · Dec 31, 2025 | $458.56K |
| Rd Expense | Q1 2026 · Dec 31, 2024 | $1.02M |
| Net Income | Q1 2026 · Dec 31, 2025 | −$18.59M |
| Net Income | Q1 2026 · Dec 31, 2024 | −$2.64M |
| Operating Income | Q1 2026 · Dec 31, 2025 | −$18.71M |
| Operating Income restated | Q1 2026 · Dec 31, 2024 | −$2.98M |
| Gross Profit | Q1 2026 · Dec 31, 2025 | $315.36K |
| Gross Profit restated | Q1 2026 · Dec 31, 2024 | $606.24K |
| Cost Of Revenue | Q1 2026 · Dec 31, 2025 | $250.04K |
| Cost Of Revenue restated | Q1 2026 · Dec 31, 2024 | $264.05K |
| Capex | Q1 2026 · Dec 31, 2024 | $116.88K |